Comparison of efficacy and safety of second-line palliative chemotherapy with paclitaxel plus raltitrexed and paclitaxel alone in patients with metastatic gastric adenocarcinoma: A randomized phase II trial.

Xiaoying Zhao,Weijian Guo,Zhiyu Chen,Xiaowei Zhang,Xiao-Dong Zhu,Wen Zhang,Lei Yang,Li-Xin Qiu,Chenchen Wang,Mingzhu Huang,Hui Yu,Jin Li,Zhe Zhang,Wenhua Li

Comparison of efficacy and safety of second-line palliative chemotherapy with paclitaxel plus raltitrexed and paclitaxel alone in patients with metastatic gastric adenocarcinoma: A randomized phase II trial.

2019

Xiaoying Zhao
Weijian Guo
Zhiyu Chen
Xiaowei Zhang
Xiao-Dong Zhu
Wen Zhang
Lei Yang
Li-Xin Qiu
Chenchen Wang
Mingzhu Huang
Hui Yu
Jin Li
Zhe Zhang
Wenhua Li

4054Background: Paclitaxel is a microtubule stabilizing agent that has been the standard second line chemotherapy in the treatment of advanced gastric cancer. This study was designed to find out th...

Keywords:

Oncology
Paclitaxel
Pathology
Raltitrexed
Adenocarcinoma
Chemotherapy
Medicine
Internal medicine
palliative chemotherapy
second line chemotherapy
gastric adenocarcinoma
in patient
advanced gastric cancer
second line

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations